Status and phase
Conditions
Treatments
About
The goal of this clinical trial is to test the safety and efficacy of an ocular medication on the treatment of pterygium.
Full description
Following informed consent, patients with pterygium who meet all eligibility criteria will be randomized to an 84-day double-blinded study to measure the safety and efficacy of the study drug as compared to placebo.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
75 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
Ashlea Beck
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal